NCT05689749View on ClinicalTrials.gov

Superb Microvascular Imaging Ultrasonography of Lacrimal Gland in Patients With Sjögren Syndrome

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

January 3, 2023

Study Completion Date

June 1, 2023

Conditions
InflammationSjogren's SyndromeGland; Inflammation
Interventions
DEVICE

Superb Microvascular Imaging (SMI) (Toshiba)

To determine whether SMI has diagnostic value for detecting the inflammatory state in the lacrimal glands in Sjögren's syndrome and whether it has any superiority compared to Power Doppler and Color Doppler modalities.

Trial Locations (1)

51700

Nigde Omer Halisdemir University, Niğde

All Listed Sponsors
lead

Nigde Omer Halisdemir University

OTHER

NCT05689749 - Superb Microvascular Imaging Ultrasonography of Lacrimal Gland in Patients With Sjögren Syndrome | Biotech Hunter | Biotech Hunter